About Hubei Honch Pharmaceutical Co. Ltd

Hubei Honch Pharmaceutical Co Ltd was established in 2007 and now covers more than 25,000 square meters. We specialize in research, production and sales of anti-tumor APIs and veterinary APIs .

In the field of anti-tumor drugs, we are integrating innovative drugs and generic drugs, such as Ixabepilone, Bortezomib, Vinorelbine Tartrate, etc. Some drugs have got cGMP, CEP and passed international inspection and on-site audit.

In the filed of veterinary drugs, we mainly produce Melbemycine oxime, selamectin and Tulathromycin which are under the process of FDA.

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPHI Milan 2026

Fiera Milano, Italy

6 Oct 2026 - 8 Oct 2026

stand 4H77
CPHI & PMEC China 2027

National Exhibition and Convention Center

16 Jun 2027 - 18 Jun 2027

stand 62G50
CPHI Frankfurt 2027

Messe, Frankfurt

9 - 11 November 2027

stand 40G56